EUVIMEDEUVIMED entdecken
Open Access

AVN944 Elicits Apoptotic Responses and Impedes Tumorigenic Potential in Ewing's Sarcoma Cells

Hanah Lim, Seonock Lee, Gamin Kim, Eun Joo Lee, Jungho Kim

International Journal of Biological Sciences · 2026

DOI: 10.7150/ijbs.116651 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2026. Verfasst von Hanah Lim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular and Cellular Biology, Department of Life Science, Sogang University, Seoul 04107, Korea. Hauptthemen laut MEDLINE: Sarcoma, Ewing, Apoptosis. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inosine monophosphate dehydrogenase 2 (IMPDH2) is implicated in survival and proliferation of cancer cells because of its role in guanine nucleotide biosynthesis. This study evaluates the efficacy of AVN944, an IMPDH2 inhibitor, as a treatment for Ewing's sarcoma, a challenging malignancy in pediatric and young adult patients. Gene expression data, as well as clinical outcomes for sarcoma patients, from The Cancer Genome Atlas (TCGA) were analyzed to determine the association between IMPDH2 expression and survival. Human Ewing's sarcoma cell lines and xenograft models were used to evaluate the cellular and in vivo effects, respectively, of AVN944. Various cellular assays, including western blotting, MTT, BrdU incorporation, and colony formation assays, were conducted to assess the impact of AVN944 on proliferation, viability, and apoptosis. IC50 values were calculated from dose-response curves. Sarcoma patients with high expression of IMPDH2 showed a trend towards poorer overall survival. In vitro, AVN944 decreased the viability and proliferation of TC71 and SK-ES-1 Ewing's sarcoma cell lines significantly, and in a dose-dependent manner. The drug induced G1 cell cycle arrest and apoptosis, as evidenced by increased expression of pro-apoptotic markers and reduced expression of cell cycle proteins. In vivo, AVN944 effectively inhibited tumor growth in xenograft models without notable toxicity. The IC50 of AVN944 was approximately 0.05 μM for both TC71 and SK-ES-1 cell lines. Thus, AVN944 displays potent anti-tumor activity against Ewing's sarcoma cells both in vitro and in vivo by inhibiting IMPDH2. The inhibitor causes cell cycle arrest and apoptosis, significantly reducing tumor viability and proliferation. These findings highlight the therapeutic potential of targeting nucleotide biosynthesis pathways in Ewing's sarcoma, suggesting that AVN944 could be a valuable addition to existing treatment protocols. Further clinical investigations are recommended to validate these preclinical outcomes and to explore integration of AVN944 into treatment regimens for Ewing's sarcoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sarcoma, EwingApoptosisHumansCell Line, TumorAnimalsCell ProliferationIMP DehydrogenaseMiceMice, NudeCell SurvivalFemaleXenograft Model Antitumor Assays

Stichwörter der Autor:innen

AVN944ApoptosisEwing' sarcomaIMPDH2Tumorigenicity.

Substanzen

IMP DehydrogenaseIMPDH2 protein, human

Autor:innen und Institutionen

  • Laboratory of Molecular and Cellular Biology, Department of Life Science, Sogang University, Seoul 04107, Korea.
  • Stress-Responding Bionanomaterial Center, Sogang University, Seoul 04107, Korea.

Zitieren

APA

Lim, H., Lee, S., Kim, G., Lee, E. J., & Kim, J. (2026). AVN944 Elicits Apoptotic Responses and Impedes Tumorigenic Potential in Ewing's Sarcoma Cells. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.116651

Vancouver

Lim H, Lee S, Kim G, Lee EJ, Kim J. AVN944 Elicits Apoptotic Responses and Impedes Tumorigenic Potential in Ewing's Sarcoma Cells. International Journal of Biological Sciences. 2026. doi:10.7150/ijbs.116651

BibTeX
@article{Lim2026,
  author = {Lim, Hanah and Lee, Seonock and Kim, Gamin and Lee, Eun Joo and Kim, Jungho},
  title = {AVN944 Elicits Apoptotic Responses and Impedes Tumorigenic Potential in Ewing's Sarcoma Cells},
  journal = {International Journal of Biological Sciences},
  year = {2026},
  doi = {10.7150/ijbs.116651}
}
Kostenlos starten →